HUE043900T2 - Selective pyy compounds and uses thereof - Google Patents

Selective pyy compounds and uses thereof

Info

Publication number
HUE043900T2
HUE043900T2 HUE14798834A HUE14798834A HUE043900T2 HU E043900 T2 HUE043900 T2 HU E043900T2 HU E14798834 A HUE14798834 A HU E14798834A HU E14798834 A HUE14798834 A HU E14798834A HU E043900 T2 HUE043900 T2 HU E043900T2
Authority
HU
Hungary
Prior art keywords
pyy compounds
selective
selective pyy
compounds
pyy
Prior art date
Application number
HUE14798834A
Other languages
Hungarian (hu)
Inventor
Soeren Oestergaard
Kilian Waldemar Conde Frieboes
Birgit Wieczorek
Jens Kaalby Thomsen
Birgitte Schjellerup Wulff
Carsten Jessen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HUE043900T2 publication Critical patent/HUE043900T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
HUE14798834A 2013-11-15 2014-11-13 Selective pyy compounds and uses thereof HUE043900T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13193082 2013-11-15
US201361906020P 2013-11-19 2013-11-19
EP14176725 2014-07-11

Publications (1)

Publication Number Publication Date
HUE043900T2 true HUE043900T2 (en) 2019-09-30

Family

ID=67003096

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14798834A HUE043900T2 (en) 2013-11-15 2014-11-13 Selective pyy compounds and uses thereof

Country Status (8)

Country Link
JP (1) JP2019189632A (en)
DK (1) DK3068421T3 (en)
ES (1) ES2732015T3 (en)
HR (1) HRP20191036T1 (en)
HU (1) HUE043900T2 (en)
PT (1) PT3068421T (en)
RU (1) RU2678312C1 (en)
TR (1) TR201910467T4 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583549A4 (en) * 2003-01-17 2006-10-04 Sod Conseils Rech Applic Peptide yy analogs
AU2009248041B2 (en) * 2008-05-16 2013-10-03 Novo Nordisk A/S Long-acting Y2 and/or Y4 receptor agonists

Also Published As

Publication number Publication date
RU2016119121A (en) 2017-12-20
DK3068421T3 (en) 2019-06-24
ES2732015T3 (en) 2019-11-20
RU2678312C1 (en) 2019-01-25
HRP20191036T1 (en) 2019-09-06
TR201910467T4 (en) 2019-08-21
JP2019189632A (en) 2019-10-31
PT3068421T (en) 2019-07-11

Similar Documents

Publication Publication Date Title
IL283040A (en) E-vaping section and e-vaping device
IL274355B (en) Aza-pyridone compounds and uses thereof
IL245045B (en) Selective pyy compounds and uses thereof
ZA201603549B (en) New pesticidal compounds and uses
IL240275B (en) Selective antisense compounds and uses thereof
GB201323008D0 (en) Compounds and uses thereof
GB201317802D0 (en) SmartHaler patent application
IL244214B (en) Thienopiperidine derivative and use thereof
IL240248A0 (en) Met-binding agents and uses thereof
GB201300707D0 (en) Compounds and processes
GB201307233D0 (en) Compounds and uses thereof
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
GB201309180D0 (en) Compounds and Their Uses
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
ZA201601880B (en) Hetero-transglycosylase and uses thereof
EP3037100A4 (en) Muscle-atrophy-preventing agent
EP3014557A4 (en) Phone-on-file
GB201300001D0 (en) Envirep - environment replicater
PT3068421T (en) Selective pyy compounds and uses thereof
AU5374P (en) Sungelodepi Angelonia angustifolia
AU5373P (en) Sungelobu Angelonia angustifolia
AU5375P (en) Sungeloho Angelonia angustifolia
GB201323005D0 (en) Compounds and uses thereof
GB201309248D0 (en) Compounds and combinations